Description
Teoxane Teosyal® PureSense Redensity 1 (2x1ml)
Teoxane Teosyal® PureSense Redensity 1 is a sterile, resorbable hyaluronic acid–based skin booster designed to improve skin quality rather than provide volumisation. It combines non-cross-linked hyaluronic acid with a dermal revitalising complex of amino acids, antioxidants, and minerals, intended to support hydration and overall skin condition. The formulation incorporates lidocaine hydrochloride to enhance patient comfort during injection.
Redensity 1 is classified as a biorevitalising injectable and is indicated for professional aesthetic use in patients presenting with early signs of skin ageing, dullness, or dehydration. Unlike volumising dermal fillers, it is designed for superficial intradermal placement and aims to support skin quality across treated areas. Clinical outcomes depend on patient-specific factors and strict adherence to the manufacturer’s Instructions for Use (IFU). Administration must be performed only by qualified medical professionals under appropriate clinical conditions .
What Teosyal® PureSense Redensity 1 Is Similar To
Teosyal® PureSense Redensity 1 belongs to the category of injectable skin boosters and biorevitalisers formulated to improve hydration and skin quality rather than restore volume. In this respect, it may be clinically compared to products such as Profhilo® or Sunekos®, which are also designed to support dermal quality through hyaluronic acid–based mechanisms.
While all three products aim to enhance skin condition, they differ in formulation and biological approach. Redensity 1 combines non-cross-linked HA with a defined complex of amino acids and antioxidants, whereas Profhilo® relies on hybrid HA complexes and Sunekos® incorporates specific amino acid blends. Longevity and treatment protocols vary between products and depend on manufacturer guidance and patient factors. Redensity 1 includes lidocaine within the formulation, which is not present in all comparable skin boosters.
This comparison is provided for clinical orientation only and does not imply interchangeability.
Treatment Areas / Indications
According to manufacturer and distributor documentation:
-
Face
-
Neck
-
Décolletage
-
Hands
Indicated for improvement of skin quality, hydration, and dermal support.
Usage / Administration (IFU-only section)
All administration parameters must strictly follow the official Teoxane IFU.
-
Injection depth: intradermal
-
Volume per injection point / site: not provided by manufacturer
-
Needle gauge: 30G (supplied)
-
Frequency / number of sessions: not provided by manufacturer
-
Professional-use disclaimer: Teosyal® PureSense Redensity 1 must be administered only by qualified medical professionals under aseptic conditions and in accordance with the manufacturer’s IFU and local regulations.
Some practitioners apply specific treatment protocols based on clinical experience; these are not included in the manufacturer’s official IFU.
Ingredient List
-
Non-cross-linked hyaluronic acid – 15 mg/mL
-
Amino acids (including glycine, proline, lysine, leucine, valine, alanine, arginine)
-
Antioxidants and minerals (dermal revitalising complex)
-
Lidocaine hydrochloride – present (0.3%)
-
Phosphate buffer
-
Water for injections
Presentation & Longevity
-
Packaging: 2 × 1.0 mL prefilled syringes
-
Needles: supplied with sterile 30G needles
-
Shelf life: not provided by manufacturer
-
Treatment longevity: not provided by manufacturer
Clinical duration may vary depending on patient factors and treatment protocol.
Safety Notes / Contraindications
Based on manufacturer documentation and standard medical-device guidance:
-
Contraindicated in patients with known hypersensitivity to hyaluronic acid, lidocaine, or any component of the formulation
-
Contraindicated in areas with active skin infection or inflammation
-
Not recommended for use during pregnancy or breastfeeding as a precaution
-
Intravascular injection must be avoided
Regulatory Status
-
CE-marked medical device
-
UKCA status: verify via authorised distributor or product packaging
Regulatory classification not specified in public documentation; verify on the product pack or manufacturer’s IFU.
FAQ
What is Teosyal® PureSense Redensity 1 used for?
Teosyal® PureSense Redensity 1 is an injectable skin booster designed to improve skin quality, hydration, and dermal condition. It is not intended for volumisation but rather for biorevitalisation of areas showing early signs of ageing or dehydration. Treatment must be carried out by qualified medical professionals in accordance with the IFU.
How does Redensity 1 differ from dermal fillers?
Unlike volumising dermal fillers, Redensity 1 uses non-cross-linked hyaluronic acid combined with amino acids and antioxidants to support skin quality. It is placed intradermally and aims to improve overall skin condition rather than restore volume or contour .
Does Redensity 1 contain lidocaine?
Yes. Teosyal® PureSense Redensity 1 contains lidocaine hydrochloride at a concentration of 0.3% to help improve patient comfort during injection. This information is provided by the manufacturer and distributors .
How long do results last?
The manufacturer does not specify a fixed duration of effect for Redensity 1. Longevity may vary depending on patient metabolism, treatment area, and treatment protocol, and should be discussed during consultation .
Who can administer Redensity 1?
Redensity 1 must only be administered by trained and qualified medical professionals operating within a regulated clinical environment and following the manufacturer’s IFU and local regulations .
